These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16089350)

  • 1. Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease.
    Portincasa P; Moschetta A; van Erpecum KJ; Vacca M; Petruzzelli M; Calamita G; Meyer G; Palasciano G
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):177-84. PubMed ID: 16089350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
    Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cholesterol-phospholipid vesicles and cholesterol crystals in human gallbladder bile.
    Schriever CE; Jüngst D
    Hepatology; 1989 Apr; 9(4):541-6. PubMed ID: 2925158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease.
    Portincasa P; Moschetta A; Palasciano G
    Ann Hepatol; 2002; 1(3):121-8. PubMed ID: 15280810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile salt-induced cholesterol crystal formation from model bile vesicles: a time course study.
    van de Heijning BJ; Stolk MF; van Erpecum KJ; Renooij W; Groen AK; vanBerge-Henegouwen GP
    J Lipid Res; 1994 Jun; 35(6):1002-11. PubMed ID: 8077840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryoelectron microscopy of a nucleating model bile in vitreous ice: formation of primordial vesicles.
    Gantz DL; Wang DQ; Carey MC; Small DM
    Biophys J; 1999 Mar; 76(3):1436-51. PubMed ID: 10049325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation.
    Wang HH; Portincasa P; Liu M; Wang DQ
    Adv Ther; 2023 Mar; 40(3):743-768. PubMed ID: 36602656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathophysiology and physical chemistry of cholesterol gallstones.
    Wang HH; Portincasa P; Wang DQ
    Front Biosci; 2008 Jan; 13():401-23. PubMed ID: 17981556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles.
    Venneman NG; van Kammen M; Renooij W; Vanberge-Henegouwen GP; van Erpecum KJ
    Biochim Biophys Acta; 2005 Jan; 1686(3):209-19. PubMed ID: 15629690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.
    Lammert F; Wang DQ; Hillebrandt S; Geier A; Fickert P; Trauner M; Matern S; Paigen B; Carey MC
    Hepatology; 2004 Jan; 39(1):117-28. PubMed ID: 14752830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile concentration promotes nucleation of cholesterol monohydrate crystals by increasing the cholesterol concentration in the vesicles.
    Van Erpecum KJ; Stolk MF; van den Broek AM; Renooij W; van de Heijning BJ; van Berge Henegouwen GP
    Eur J Clin Invest; 1993 May; 23(5):283-8. PubMed ID: 8354334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary lipids, water and cholesterol gallstones.
    van Erpecum KJ
    Biol Cell; 2005 Nov; 97(11):815-22. PubMed ID: 16232124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences.
    Wang DQ; Carey MC
    J Lipid Res; 1996 Dec; 37(12):2539-49. PubMed ID: 9017506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile.
    Konikoff FM; Cohen DE; Carey MC
    J Lipid Res; 1994 Jan; 35(1):60-70. PubMed ID: 8138723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of bile salt hydrophobicity on model bile vesicle morphology.
    van de Heijning BJ; Stolk MF; van Erpecum KJ; Renooij W; van Berge Henegouwen GP
    Biochim Biophys Acta; 1994 May; 1212(2):203-10. PubMed ID: 8180246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.
    Moschetta A; Bookout AL; Mangelsdorf DJ
    Nat Med; 2004 Dec; 10(12):1352-8. PubMed ID: 15558057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways of cholesterol crystallization in model bile and native bile.
    Portincasa P; Moschetta A; van Erpecum KJ; Calamita G; Margari A; vanBerge-Henegouwen GP; Palasciano G
    Dig Liver Dis; 2003 Feb; 35(2):118-26. PubMed ID: 12747631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bile acid hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles.
    Stolk MF; van de Heijning BJ; van Erpecum KJ; van den Broek AM; Renooij W; van Berge-Henegouwen GP
    J Hepatol; 1994 Jun; 20(6):802-10. PubMed ID: 7930482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol saturation rather than phospholipid/bile salt ratio or protein content affects crystallization sequences in human gallbladder bile.
    Venneman NG; Portincasa P; Vanberge-Henegouwen GP; van Erpecum KJ
    Eur J Clin Invest; 2004 Oct; 34(10):656-63. PubMed ID: 15473890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: pathogenesis of gallstones.
    Dowling RH
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.